MedDataX Logo

Analysis of Cerebrospinal Fluid in Patients With Cerebral Toxoplasmosis at CHSD (2004-2024)

NCT ID: NCT07044037

Last Updated: 2025-06-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

53 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-07-01

Study Completion Date

2024-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study looks at patients who were treated for cerebral toxoplasmosis at CHSD between 2004 and 2024. It focuses on analyzing their cerebrospinal fluid (CSF) to better understand the biological signs of the disease. The goal is to see if CSF results can show signs of meningitis, even though it's not commonly reported, and to describe any co-infections, symptoms, brain imaging findings, and patient outcomes.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Study of a Cohort of Non-HIV Immunocompromised Patients With Toxoplasmosis at the Strasbourg University Hospital

NCT07299500

Cerebral Toxoplasmosis
RECRUITING

Cerebral Toxoplasmosis and AIDS

NCT00803621

Cerebral Toxoplasmosis AIDS
COMPLETED

Pregnancy and Congenital Toxoplasmosis

NCT05774496

Congenital Toxoplasmosis Retinochoroiditis
COMPLETED

Isolated Positive Toxoplasma Gondii PCR in Blood

NCT07054918

Toxoplasmosis
NOT_YET_RECRUITING

Lyon Cohort of Maternal and Congenital Toxoplasma Infections

NCT02936921

Toxoplasmosis, Congenital
RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Toxoplasmosis, Cerebral Toxoplasmosis Meningitis HIV Infections Cerebrospinal Fluid Central Nervous System Infections

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

\- Adult patients (age 18 years) hospitalized at CHSD between January 1, 2004 and March 31, 2024 for cerebral toxoplasmosis

Exclusion Criteria

\- Under 18 years ols
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Hospitalier de Saint-Denis

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

France

Saint-Denis, France, France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

0076_NEUROLOGIE

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Epidemiological, Clinical and Biological Caracteristics of Patients Presenting With Invasive Meningococcal Disease
NCT05981599 UNKNOWN
New Diagnostic Approach for Congenital Toxoplasmosis
NCT03385499 UNKNOWN NA
Neurological Consequences of Perinatal Listeriosis Infection
NCT02580812 COMPLETED NA
Diagnosis of Toxoplasma Gondii Infection by Exploration of Cellular Immunity (TOXCELL)
NCT04825600 COMPLETED NA
Study of Decreasing Kinetics of the Leptospiremia During Antibiotic Treatment of Leptospirosis in Martinique
NCT02000635 UNKNOWN
Prognostic Value of Neonatal Markers for the Development of Neurosensorial Sequelae in Children Infected by Cytomegalovirus in Utero
NCT01923636 COMPLETED NA
Acute Infectious Encephalitis and Myelitis in Guadeloupe by New Generation Sequencing
NCT07251049 RECRUITING
Creation of a Biotheque of Patients of Seine-Maritime With Meningococcal Infection
NCT00450632 COMPLETED
Measuring the Prevalence of Toxoplasmosis and Its Socio-economic Consequences
NCT05860998 UNKNOWN
Does Normal Brain Imaging Predict Normal Neurodevelopmental Outcome in Fetuses With Proven Cytomegalovirus Infection?
NCT00872703 COMPLETED
International Cohort Study of Children Born to Women Infected With Zika Virus During Pregnancy
NCT04118738 COMPLETED
Evaluation of Biological Biomarkers Diagnostic of Toxoplasmosis Uveitis
NCT02843438 COMPLETED NA
Optimizing the Diagnosis of Pneumocystis in Immunocompromised Patients
NCT06890078 NOT_YET_RECRUITING
Prevention of Congenital Toxoplasmosis With Pyrimethamine + Sulfadiazine Versus Spiramycine During Pregnancy
NCT01189448 COMPLETED PHASE3
Detection of Human Cytomegalovirus in the Saliva
NCT00815802 COMPLETED
A Prospective Cohort Pilot Study of the Clinical and Molecular Epidemiology of Staphylococcus Aureus in Pregnant Women at the Time of Group B Streptococcal Screening in a Large Urban Medical Center in Chicago, IL USA
NCT00532324 COMPLETED NA
Evaluation of Viral Replication by Tonate Virus (TONV) and Zika Virus (ZIKV), Within an ex Vivo Trophoblast and Placental Model
NCT05589012 UNKNOWN
Zika in Infants and Pregnancy (ZIP)
NCT02856984 COMPLETED
Establishment of Prevention and Control System of Central Nervous System Infection
NCT04722328 NOT_YET_RECRUITING
Pediatric Infectious Disease Precision Medicine Using Sequencing Evaluation of CSF
NCT03796546 COMPLETED
Etiology of Orphan Community-based Meningitis and Meningo-encephalitis.
NCT02868593 UNKNOWN NA
Improving the Diagnosis of Meningitis in Emergency Rooms
NCT02858661 COMPLETED NA
Seropositivity and Adverse Birth Events in Migrants From Bilharzia-endemic Areas
NCT03158298 TERMINATED
Chlamydia Tracomatis and Other Lower Genital Tract Infections Among Women With Unexplained Early Miscarriage
NCT04152278 COMPLETED
The Relationship Between GBS Screening in Pregnant Women Insured in Maccabi Healthcare Services (MHS) and Early-onset Neonatal Disease in Israel
NCT04222907 COMPLETED